Argenta Discovery Ltd.

Royaume‑Uni

 
Quantité totale PI 50
Rang # Quantité totale PI 27 413
Note d'activité PI 0/5.0    0
Rang # Activité PI 1 653 802

Brevets

Marques

0 0
0 0
50 0
0
 
Dernier brevet 2011 - Bicyclo[2.2.1]hept-7-ylamine der...
Premier brevet 2003 - Substituted thienyl-hydroxamic a...

Derniers inventions, produits et services

2011 Invention Bicyclo[2.2.1]hept-7-ylamine derivatives and their uses. Compounds of formula (I) have muscarini...
2009 Invention Quinuclidine derivatives and their use as muscarinic receptor antagonists for the treatment of as...
Invention Quinuclidine derivatives and their use as muscarinic receptor antagonists. The invention provides...
Invention Azonia bicycloalkanes as m3 muscarinic acetylcholin receptor antagonists. This invention relates ...
Invention 2- (9h-xanthen-9-yl) -oxazol derivatives as m3 muscarinic receptor antagonists for the treatment ...
2008 Invention 3,4,6,7-tetrahydro-1 h-pyrrolo[3,4-d]pyrimidine-2,5-diones and their therapeutic use. A compound ...
Invention 3,4,6,7-tetrahydro-1h-pyrrolo[3,4-d]pyrimidine-2,5-diones and their therapeutic use. Compounds in...
Invention 6,6-fused bicyclic aromatic compounds and their therapeuti use. This invention relates to a class...
Invention Indolizine derivatives with crth2 receptor affinity for the treatment of inflammatory diseases. C...
Invention Heterocyclic compounds used in the treatment of diseases where enhanced m3 receptor activation is...
Invention Inhalation therapy for respiratory disorders. The present invention relates to a novel method of ...
Invention Nitrogen containing heterocyclic compounds useful as bifunctional modulators of m3 receptors and ...
Invention 1-aza-bicyclo [2.2.2] octane derivatives useful as muscarinic receptor antagonists. The invention...
Invention Bicyclor [2.2.1] hept-7-ylamine derivatives and their use in the treatment of diseases and condit...
Invention Heterocyclic derivatives as m3 muscarinic receptors. This invention relates to M3 antagonists of...
Invention Heterocyclic derivatives as m3 muscarinic receptors. This invention relates to M3 antagonists of ...
Invention New salt. The invention provides [2-(4-chloro-benzyloxy)-ethyl]-[2-((R)-cyclohexyl-hydroxy- pheny...
Invention Oxazole and thiazole derivatives and their uses 2. Compounds of formula (I): wherein A, X, R1, R2...
Invention Napadisylate salt of a muscarinic m3 antagonist. The invention provides [2-((R)-Cyclohexyl-hydrox...
Invention Combination of a muscarinic receptor antagonist and a beta-2-adrenoceptor agonist. The invention ...
Invention Bicyclo[2.2.1]hept-7-ylamine derivatives and their use as m3 muscarinic receptor modulators. The ...
Invention Nitrogen containing hetrocyclic compounds useful as bifunctional modulators of m3 receptors and b...
Invention Combinations with a muscarinic receptor antagonist. The invention provides a pharmaceutical produ...
Invention Napadisylate salt of a muscarinic m3 antagonist. The invention provides [2-(4-chloro-benzyloxy)-e...
2007 Invention Indolizineacetic acids and their therapeutic use as ligands of the crth2 receptor. Compounds of ...
Invention Indolizineacetic acids and their therapeutic use as ligands of the crth2 receptor. Compounds of f...
Invention 4- (4-cyanophenyl) -1- (3-trifluoromethylphenyl) -3,4, 6, 7-tetrahydro-1h-pyrrolo [3, 4- d] pyrim...
Invention Dimers of 5- [ (4-cyanophenyl) sulfinyl] -6-methyl-2-oxo-1- [3- (trifluoromethyl)phenyl] -1,2-dih...
Invention Nitrogen containing heterocyclic compounds useful as m3-receptor modulators. A compound of formul...
Invention Bicyclo [2. 2. 1] hept-7-ylamine derivatives and their use. According to the invention, there is ...
Invention Azole and thiazole derivatives and their uses. The present invention provides compounds of formul...
Invention Tetrahydropyrrolopyrimidinediones and their use as human neutrophil elastase inhibitors. Compound...
Invention Bicycl0 [2. 2. 1] he pt- 2-ylamine derivates and their use. A named compound of formula (I): havi...
Invention Oxazole and thiazole derivatives and their uses. A quaternary ammonium compound of formula (I) ha...
Invention Bicyclor[2.2.1]hept-7-ylamine derivatives as muscarinic m3 receptor modulators. Representatives o...
2006 Invention Crth2 antagonists. The following compounds are CRTH2 antagonists, useful in treatment of respira...
Invention Crth2 antagonists. The following compounds are CRTH2 antagonists, useful in treatment of respirat...
Invention Cyclic amine derivatives and their uses. Compounds of formula (I) have muscarinic M3 receptor mo...
Invention Indolizine derivatives as ligands of the crth2 receptor. Compounds of formula (I) are CRTH2 anta...
Invention Thiazole compounds and their use as pgd2 antagonists. A compound for use as a PGD2 antagonist is...
Invention Bicyclo[2.2.1]hept-7-ylamine derivatives and their uses. 8-alkyl)-, cycloalkyl or heterocycloalky...
Invention Indolizine derivatives. Compounds of formula (I) are ligands of the CRTH2 receptor and are usefu...
Invention Dihydropyrimidone multimers and their use as human neutrophil, elastase inhibitors. A compound o...
Invention Multimers of heterocyclic compounds and their use. A compound of formula (I): M-L-M, wherein L i...
2005 Invention Pyrimidine compounds as histamine modulators. The present invention relates to novel pyrimidine ...